Showing results (1-10 of 396) with videos related to
Sort By:
Pageof 40
Current Opinion in Nephrology and Hypertension|January 17, 2015
Antihypertensive mechanisms of intra-renal dopamineMing-Zhi Zhang, Raymond C HarrisComprehensive Physiology|June 5, 2013
Cyclooxygenase metabolites in the kidneyRaymond C Harris, Ming-Zhi ZhangBio-Protocol|March 3, 2021
Immunohistochemical Staining of CD8α in Diabetic Mouse KidneyMing-Zhi Zhang, Raymond C HarrisSeminars in Nephrology|February 25, 2026
The Role of the Epidermal Growth Factor Receptor in Kidney Tubulointerstitial FibrosisRaymond C Harris, Ming-Zhi ZhangCurrent Hypertension Reports|March 13, 2012
Dopamine, the kidney, and hypertensionRaymond C Harris, Ming-Zhi ZhangAmerican Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 19, 2005
Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidneyBing Yao, Raymond C Harris, Ming-Zhi ZhangHypertension (Dallas, Tex. : 1979)|September 23, 2009
Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathwayBing Yao, Raymond C Harris, Ming-Zhi ZhangAmerican Journal of Physiology. Renal Physiology|December 29, 2005
Nitric oxide stimulates cyclooxygenase-2 in cultured cTAL cells through a p38-dependent pathwayHui-Fang Cheng, Ming-Zhi Zhang, Raymond C HarrisDiabetes|April 8, 2014
Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagyMing-Zhi Zhang, Yinqui Wang, Paisit Paueksakon, et al.American Journal of Physiology. Renal Physiology|December 7, 2007
Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenaseBing Yao, Jie Xu, Raymond C Harris, et al.Pageof 40